The AlphaLISA™ SureFire® Biotin-Free Human Total FOXA1 assay is a sandwich immunoassay for quantitative detection of total FOXA1 in cellular lysates using Alpha Technology.
| Feature | Specification |
|---|---|
| Application | 細胞シグナル伝達 |
| Protocol Time | 2h at RT |
| Sample Volume | 10 µL |
The AlphaLISA™ SureFire® Biotin-Free Human Total FOXA1 assay is a sandwich immunoassay for quantitative detection of total FOXA1 in cellular lysates using Alpha Technology.
Loading...
Forkhead Box A1 (FOXA1) is a pioneer transcription factor belonging to the forkhead family that plays essential roles in establishing and maintaining cell lineage identity in endodermal and hormone-responsive tissues including the liver, pancreas, lung, prostate, and breast. As a pioneer factor, FOXA1 binds compacted chromatin and displaces linker histones to open chromatin at enhancer regions, enabling subsequent binding of other transcription factors including the androgen receptor (AR) and estrogen receptor (ER). FOXA1 is a critical determinant of AR and ER cistrome specificity — the genome-wide binding landscape of these nuclear receptors is substantially shaped by FOXA1-mediated chromatin accessibility. In prostate cancer, FOXA1 is essential for AR-driven transcriptional programs, and FOXA1 mutations identified in CRPC alter its chromatin binding and reprogramming activity, driving aberrant AR signaling. In breast cancer, FOXA1 is a marker of luminal subtype and ER-positive disease, where it cooperates with ER to regulate proliferative gene expression. FOXA1 mutations and amplifications have been identified as drivers of endocrine resistance in breast cancer, making FOXA1 an emerging therapeutic target and biomarker of treatment response.
The AlphaLISA SureFire Biotin-Free Human Total FOXA1 Detection Kit is a sandwich immunoassay for the quantitative detection of total FOXA1 in cellular lysates, using Alpha Technology.
Formats:
AlphaLISA SureFire Biotin Free kits are compatible with:
AlphaLISA SureFire Biotin Free kits can be used for:
The Total-AlphaLISA SureFire Biotin Free assay measures the expression level of a target protein in a biological sample (e.g. cell lysate).
The Total-AlphaLISA SureFire Biotin Free assay uses two antibodies which recognize two different distal epitopes on the target protein. AlphaLISA assays require two bead types: Acceptor and Donor Beads. Acceptor Beads are coated with a proprietary CaptSure™ agent to specifically immobilize the assay specific antibody, labeled with a CaptSure tag. Donor Beads are coated with a proprietary CaptSure3 agent to capture one of the detection antibodies, which is labeled with the CaptSure3 tag. In the presence of target protein, the two antibodies bring the Donor and Acceptor Beads in close proximity whereby the singlet oxygen transfers energy to excite the Acceptor Bead, allowing for the generation of a luminescent Alpha signal. The amount of light emission is directly proportional to the quantity of protein present in the sample.
The two-plate protocol involves culturing and treating the cells in a 96-well plate before lysis, then transferring lysates into a 384-well OptiPlate™ plate before the addition of Total-AlphaLISA SureFire Biotin Free detection reagents. This protocol enables cell viability and confluence to be monitored. In addition, lysates from a single well can be used to measure multiple targets.
Detection of Total target protein with AlphaLISA SureFire Biotin Free reagents can be performed in a single plate used for culturing, treatment, and lysis. No washing steps are required. This HTS designed protocol allows for miniaturization while maintaining robust AlphaLISA SureFire quality.
Dilutions of FOXA1 recombinant protein were prepared in Lysis Buffer and FOXA1 levels were evaluated using the AlphaLISA SureFire Ultra Biotin Free assay. For the detection step, 10 µL of diluted protein was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at room temperature. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings. Dotted line represents assay background.
FOXA1 levels were assessed in HeLa-WT and FOXA1 KO (Abcam, ab261823) cell lines cultured to confluence in T175 flasks at 37°C, 5% CO2. Cells were lysed in 4 mL of Lysis Buffer for 10 minutes at RT with shaking.
Lysate was diluted in Lysis Buffer and FOXA1 Total levels were evaluated by AlphaLISA SureFire Biotin Free assay. For the detection step, 10 µL of lysate (approximately 50,000 cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at room temperature. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
FOXA1 was detected in WT but not KO cells, confirming the specificity of the assay for the detection of FOXA1 protein.
Adherent cells were grown to confluency in a T175 flask in complete medium and lysed with Lysis Buffer at a density of 0.5 x 106 cells/mL. Suspension cells were harvested, spun down and lysed with Lysis Buffer at a density of 1.6 x 106 cells/mL.
FOXA1 Total levels were evaluated using the AlphaLISA SureFire Biotin Free assay. For the detection step, 10 µL of cell lysate (5,000 adherent and 16,000 suspension cells) were transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor Mix and incubated for 1 hour at RT. Finally, 5 µL of Donor Mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
FOXA1 expression was detected in a wide range of human cell lines.
Cell lysate was prepared from HEK293 cells cultured to confluence in a T175 flask and lysed in 3 mL of Lysis Buffer for 10 minutes at RT with shaking.
Lysate was serially diluted in Lysis Buffer and FOXA1 levels were evaluated using the AlphaLISA SureFire Biotin Free assay. For the detection step, 10 µL of lysate was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at room temperature. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
Approximate number of cells per datapoint is indicated. The dotted line represents assay background. The assay can detect FOXA1 expression in less than 500 cells.
| Application |
Cell Signaling
|
|---|---|
| Automation Compatible |
Yes
|
| Brand |
AlphaLISA SureFire Biotin-Free
|
| Detection Modality |
Alpha
|
| Product Group |
Kit
|
| Protocol Time |
2h at RT
|
| Sample Volume |
10 µL
|
| Shipping Conditions |
Shipped in Blue Ice
|
| Target |
FOXA1
|
| Target Class |
Phosphoproteins
|
| Target Species |
Human
|
| Technology |
Alpha
|
| Therapeutic Area |
Oncology
|
| Unit Size |
500 Assay Points
|
Are you looking for resources, click on the resource type to explore further.
The definitive guide for setting up a successful AlphaLISA SureFire Ultra assay
Several biological processes are regulated by...
Loading...
We are here to answer your questions.